Addressing Microaggressions in Racially Charged Patient-provider Interactions: A Pilot Randomized Trial

November 30, 2019 updated by: Jonathan Kanter, University of Washington

Reducing Racial Disparities in Healthcare: Developing Social Connections Through Behavioral Science

Racial bias in medical care is a significant public health issue, with increased focus on microaggressions and the quality of patient-provider interactions. Innovations in training interventions are needed to decrease microaggressions and improve provider communication and rapport with patients of color during medical encounters. This paper presents a pilot randomized trial of an innovative clinical workshop that employed a theoretical model from social and contextual behavioral sciences. The intervention was largely informed by research on the importance of mindfulness and interracial contact involving reciprocal exchanges of vulnerability and responsiveness, to target processes centered on the providers' likelihood of expressing biases and negative stereotypes when interacting with patients of color in racially challenging moments. Twenty-five medical student and recent graduate participants were randomized to a workshop intervention or no intervention. Outcomes were measured via provider self-report and observed changes in targeted provider behaviors. Specifically, two independent, blind teams of coders assessed provider emotional rapport and responsiveness during simulated interracial patient encounters with standardized Black patients who presented specific racial challenges to participants. We observed greater improvements in observed emotional rapport and responsiveness (indexing fewer microaggressions), improved self-reported explicit attitudes toward minoritized groups, and improved self-reported working alliance and closeness with the Black standardized patients were observed and reported by intervention participants. Effects largely were driven by improvements by the White participants.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

25

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Washington
      • Seattle, Washington, United States, 98103
        • Bastyr University Seattle Clinic

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Medical students or recent graduates of Bastyr University.

Exclusion Criteria:

  • None

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention
The bias-reduction intervention opened with a didactic on health disparities, stereotypes, microaggressions, interracial provider-patient interactions and racism. Then, a guided, interracial eye-contact mindfulness exercise was performed to increase providers' awareness and acceptance of subtle bias that occurs in interracial interactions. Then, in small, mixed-race groups, participants practiced the above mindfulness skills while reciprocally sharing and responding with empathy to each other's personal life histories and personal narratives of loss and/or betrayal. The intervention ended with explicit practice component, involving practice and feedback.
A training for doctors
No Intervention: Control
The control condition was a waitlist condition. Doctors were given workshop materials after the study ended.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Emotional Rapport Building from Pre- to Post-Intervention
Time Frame: Pre-test occurred on Day 1, the Intervention occurred Day 2, and then post-test occurred Day 4ater after the intervention
We used the Roter Interactional Analysis System (RIAS), a turn-by-turn coding system in which each provider and patient utterance is coded into one of 40 categories of speech, which can be combined to create various summary scores. RIAS codes have demonstrated validity with a variety of samples and medical contexts. For the current study, two trained RIAS coders provided ratings, and both coders coded a subset of tapes (10%) for reliability (r= 0.92). Because standardized patients in our study were following a protocol and not responding naturally, we analyzed only provider codes, specifically the Emotional Rapport Building summary score which is a composite of doctor codes including emotional statements, legitimizing statements, concern statements, partnership statements, self-disclosure statements, and reassurance statements.
Pre-test occurred on Day 1, the Intervention occurred Day 2, and then post-test occurred Day 4ater after the intervention
Change in responsiveness to racial challenges from Pre- to Post-Intervention
Time Frame: Pre-test occurred on Day 1, the Intervention occurred Day 2, and then post-test occurred Day 4ater after the intervention
We modified observer-based responsiveness coding systems used in previous research that operationalized positive responsiveness in dyads as concrete instances of understanding, validation, and caring on a 0 to 3 scale. We expanded the previous 0 code, which originally combined both no responses (e.g., simply ignoring the challenge) and invalidating responses (e.g., defensive or microaggressive responses), into a negative responsiveness dimension and provided anchors and examples for each score, producing a Likert scale from - 3 to + 3, as shown in Table 3. Four coders were trained to high reliability.
Pre-test occurred on Day 1, the Intervention occurred Day 2, and then post-test occurred Day 4ater after the intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in offensiveness from Pre- to Post-Intervention
Time Frame: Pre-test occurred on Day 1, the Intervention occurred Day 2, and then post-test occurred Day 4
Single-item question analyzed by responsiveness coders, asking "did the doctor say anything offensive?"
Pre-test occurred on Day 1, the Intervention occurred Day 2, and then post-test occurred Day 4
Change in Bias from Pre- to Post-Intervention
Time Frame: Pre-test occurred on Day 1, the Intervention occurred Day 2, and then post-test occurred Day 4
Single-item question analyzed by responsiveness coders, asking "Was the doctor overtly biased against the patient?"
Pre-test occurred on Day 1, the Intervention occurred Day 2, and then post-test occurred Day 4
Change in Recommendations from Pre- to Post-Intervention
Time Frame: Pre-test occurred on Day 1, the Intervention occurred Day 2, and then post-test occurred Day 4
Single-item question analyzed by responsiveness coders, asking "Would you recommend that a Black friend with the same problem as this patient see this doctor over any other doctor?"
Pre-test occurred on Day 1, the Intervention occurred Day 2, and then post-test occurred Day 4
Change in Patient experience from Pre- to Post-Intervention
Time Frame: Pre-test occurred on Day 1, the Intervention occurred Day 2, and then post-test occurred Day 4
Single-item question analyzed by responsiveness coders, asking "Do you think the patient had a positive experience?"
Pre-test occurred on Day 1, the Intervention occurred Day 2, and then post-test occurred Day 4
Change in Ethnocultural empathy from Pre- to Post-Intervention
Time Frame: Pre-test occurred on Day 1, the Intervention occurred Day 2, and then post-test occurred Day 4
Everyday Multicultural Competencies/Revised Scale of Ethnocultural Empathy (EMC/RSEE), which has strong evidence for factor structure, reliability and discriminant validity. There are multiple subscales; we were interested in empathic perspective-taking and acting as an ally
Pre-test occurred on Day 1, the Intervention occurred Day 2, and then post-test occurred Day 4
Change in attitudes toward various ethnic/racial groups from Pre- to Post-Intervention
Time Frame: Pre-test occurred during screening, between 5 days and 4 months prior to Intervention; post-test occurred two days after intervention.
To assess explicit attitudes towards various ethnic and racial groups, participants provided feeling thermometer ratings for different groups of people, including African Americans and 13 other demographic categories, from 0 (extremely unfavorable) to 100 (extremely favorable). Low scores on feeling thermometers are interpreted as a simple indicator of explicit prejudice.
Pre-test occurred during screening, between 5 days and 4 months prior to Intervention; post-test occurred two days after intervention.
Change in Working alliance from Pre- to Post-Intervention
Time Frame: Pre-test occurred on Day 1, the Intervention occurred Day 2, and then post-test occurred Day 4
After each standardized patient interaction, participants completed the 12-item Bond subscale of the Working Alliance Inventory (WAI), a widely used measure to assess the provider-patient alliance in therapeutic interactions. Bond subscale items ask about specific feelings toward the patient, including "I respect this patient."
Pre-test occurred on Day 1, the Intervention occurred Day 2, and then post-test occurred Day 4
Change in Interaction closeness from Pre- to Post-Intervention
Time Frame: Pre-test occurred on Day 1, the Intervention occurred Day 2, and then post-test occurred Day 4
After each standardized patient interaction, participants answered three questions about their experience of the interaction. First, they completed the Inclusion of the Other in the Self (IOS) scale, a well-validated, single-item, pictorial measure of relational closeness which has been used to assess closeness in interracial contexts and between patients and providers. The other two closeness items were the following: 1) Relative to all your other relationships with patients (outside of this study), how would you characterize your relationship with this patient? and 2) Relative to what you know about other patient's relationships with their doctors, how would you characterize your relationship with this patient? Agreement with these items was assessed on a 7-point Likert scale ranging from 1 (less close) to 7 (more close).
Pre-test occurred on Day 1, the Intervention occurred Day 2, and then post-test occurred Day 4

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Jonathan Kanter, Ph.D., University of Washington

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 24, 2016

Primary Completion (Actual)

September 25, 2016

Study Completion (Actual)

September 25, 2016

Study Registration Dates

First Submitted

October 30, 2018

First Submitted That Met QC Criteria

November 25, 2019

First Posted (Actual)

November 29, 2019

Study Record Updates

Last Update Posted (Actual)

December 3, 2019

Last Update Submitted That Met QC Criteria

November 30, 2019

Last Verified

November 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • Bastyr_16-1557

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

IPD Plan Description

IPD will be shared by request so as not to violate individual privacy concerns.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Racism

Clinical Trials on Bias-reduction Intervention

3
Subscribe